|
Medtronic received information that prior to use of an eopa arterial cannula, it was reported that before using the product the customer noticed that the introducer was too small for the cannula.The device was replaced.There was no patient involvement, so no adverse effect occurred.
|
|
Device evaluation summary: visual inspection shows no outward signs of any damage.The hemostasis cap id and dilator od were measured using a keyence vision scope.Hemostasis cap id was measured to be 0.231 inches, the specification, 06689 has the id to be 0.225 +/- 0.005 inches.Dilator od was measured to be 0.239 inches, the specification, 0804700 has the od to be 0.242 + 0.002 / -0.004 inches.The dilator was inserted and removed from the hemostasis cap and there was resistance noted.Reason for return was undetermined.This regulatory report is being submitted due to retrospective review through capa 624392.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|